MAHALIFE
MAHAMAYA LIFESCIENCES financials
- Market cap
- ₹433 Cr
Quarterly results
| Line item | Q2 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|
| Revenue | 146 | 163 | 166 |
| EBITDA | 13 | 15 | 17 |
| Net profit | 7 | 8 | 8 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −5.3% YTD
YTD: ₹187.7 on 1 Jan 2026 → ₹177.75. High ₹200.1 (24 Aug 2026), low ₹137.15 (23 Mar 2026).
Balance sheet
| Year ending | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity capital | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹18 Cr | ₹23 Cr |
| Reserves | ₹14 Cr | ₹18 Cr | ₹23 Cr | ₹40 Cr | ₹99 Cr |
| Borrowings | ₹19 Cr | ₹24 Cr | ₹55 Cr | ₹68 Cr | ₹91 Cr |
| Other liabilities | ₹21 Cr | ₹34 Cr | ₹33 Cr | ₹110 Cr | ₹98 Cr |
| Total liabilities | ₹56 Cr | ₹78 Cr | ₹112 Cr | ₹236 Cr | ₹310 Cr |
| Fixed assets | ₹20 Cr | ₹21 Cr | ₹21 Cr | ₹31 Cr | ₹38 Cr |
| Capital work in progress | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹0 Cr | ₹6 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹34 Cr | ₹54 Cr | ₹88 Cr | ₹205 Cr | ₹267 Cr |
| Total assets | ₹56 Cr | ₹78 Cr | ₹112 Cr | ₹236 Cr | ₹310 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
Since Nov 2025, the public added +3.75 pp while DIIs trimmed −2.15 pp. The shareholder count shrank 44% to 584.
- Promoters
- 56.4%
- FIIs
- 4.8%
- DIIs
- 2.5%
- Public
- 36.4%
Since Nov 2025
- Public +3.75 pp
- DIIs −2.15 pp
- FIIs −1.62 pp
Who bought this quarter
since Nov 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Kedia Securities Private Limited newly disclosed 4.53% held
- Gujrani Consultancy Services Private Limited newly disclosed 1.08% held
- Gujrani Foods Private Limited newly disclosed 1.08% held
The same filing shows 2 holders trimming and 4 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of MAHAMAYA LIFESCIENCES LIMITED above SEBI's 1% disclosure line, and what changed since Nov 2025.
| Holder | Stake | Change |
|---|---|---|
| Krishnamurthy Ganesan | 21.86% | unchanged |
| Prashant Krishnamurthy | 17.61% | unchanged |
| Lalitha Krishnamurthy | 16.88% | unchanged |
| Pink Tiger Alliances Llp | 10.35% | unchanged |
| Kedia Securities Private Limited | 4.53% | newly disclosed |
| NAV Capital Vcc - NAV Capital Emerging Star Fund FPI fund | 2.53% | −0.24 pp |
| Minerva Ventures Fund FPI fund | 2.28% | unchanged |
| Multiplier Share And Stock Advisors Pvt Ltd | 1.28% | unchanged |
| Gujrani Consultancy Services Private Limited | 1.08% | newly disclosed |
| Gujrani Foods Private Limited | 1.08% | newly disclosed |
| Navbharat Investment Trust-Navbharat Investment Opportunitie AIF | 1.03% | −0.66 pp |
| Ebisu Global Opportunities Fund Limited FPI fund | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse MAHAMAYA LIFESCIENCES LIMITED
Guides on how to read this kind of business and the numbers that matter.